Summary Stage 2018: Pancreas
Summary Stage 2018
Notes
Pancreas
8000-8700, 8720-8790, 8971
C250-C254, C257-C259
C250 Head of pancreas
C251 Body of pancreas
C252 Tail of pancreas
C253 Pancreatic duct
C254 Islets of Langerhans
C257 Other specified parts of pancreas
C258 Overlapping lesion of pancreas
C259 Pancreas, NOS
Note 1: The following sources were used in the development of this chapter
- SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
- SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
- Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
- Chapter 28 Exocrine Pancreas, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
- Chapter 34 Neuroendocrine Tumors of the Pancreas, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
- Neuroendocrine Tumors of the Pancreas, from the AJCC Cancer Staging System Version 9 (2023). Used with permission of the American College of Surgeons, Chicago, Illinois.
Note 2: See the following chapters for the listed histologies
- 8710-8714, 8800-8934, 8940-8970, 8972-9138, 9141-9582: Soft Tissue
- 8935-8936: GIST
- 9140: Kaposi Sarcoma
- 9700-9701: Mycosis Fungoides
Note 3: For tumors of the islet cells, determine which subsite of the pancreas is involved and use that primary site code. If the subsite cannot be determined, use the general code for Islets of Langerhans, C254.
Note 4: The terms "abutment," "abut(s)," "encases," or "encasement" of the major blood vessels can be interpreted as involvement of these structures.
NAACCR Item
NAACCR #764SS2018 | Description |
---|---|
0 | In situ, intraepithelial, noninvasive
|
1 | Localized only (localized, NOS)
|
2 | Regional by direct extension only
|
3 | Regional lymph node(s) involved only
|
4 | Regional by BOTH direct extension AND regional lymph node(s) involved
|
7 | Distant site(s)/lymph node(s) involved
|
9 | Unknown if extension or metastasis |
(1) Fritz AG, Ries LAG (eds). SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998), National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998
(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). SEER Summary Staging Manual-2000: Codes and Coding Instructions, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05. American Joint Committee on Cancer (Chicago, IL)
(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. Principles of Cancer Staging. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017
(5) Kakar, S., Pawlik, T.M., Vauthey, J.N., et al. Exocrine Pancreas. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017
(6) Bergsland, E.K., Woltering, E.A., Klimstra, D.S., et al. Neuroendocrine Tumors of the Pancreas. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017
(7) Neuroendocrine Tumors of the Pancreas, from the AJCC Cancer Staging System Version 9 (2023). Used with permission of the American College of Surgeons, Chicago, Illinois.